{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-026931","form_type":"8-K","ticker":"OMER","cik":"0001285819","company_name":"OMEROS CORP","filed_at":"2025-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.584327+00:00","generated_at":"2026-05-17T12:52:10.497041+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Omeros Q2 net loss narrows to $25.4M; narsoplimab PDUFA extended to Dec 2025; debt reduced by $80M","bullets":["Net loss of $25.4M ($0.43/sh) vs $56.0M ($0.97/sh) a year ago; cash, short-term investments $28.7M at June 30.","Post-quarter: raised $20.6M net from Polar Asset Management (5.37M shares at $4.10, 14% premium) plus $2.1M from ATM.","Narsoplimab BLA PDUFA date extended to Dec 26, 2025; FDA expects labeling talks by Oct. EMA MAA validated, opinion mid-2026.","Exchanged $70.8M of 2026 Notes for 2029 Notes; remaining 2026 Notes reduced to $17.1M; avoided $20M prepayment on term debt.","In talks for potential asset deal with multi-billion total value; upfront cash would repay $67.1M term loan and $17.1M notes."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-026931","json":"https://secwatch.observer/filing/0001437749-25-026931.json","markdown":"https://secwatch.observer/filing/0001437749-25-026931.md","text":"https://secwatch.observer/filing/0001437749-25-026931.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925026931/0001437749-25-026931-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925026931/omer20250521_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T12:52:10.497041+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}